Androstenedione is the preferred androgen source in hormone refractory prostate cancer--response

Clin Cancer Res. 2014 Sep 15;20(18):4972-3. doi: 10.1158/1078-0432.CCR-14-1536.

Authors

Christopher M Hovens¹, Matthew K H Hong¹, Niall M Corcoran²

Affiliations

¹ Department of Surgery, University of Melbourne and Royal Melbourne Hospital, Parkville, Victoria, Australia.
² Department of Surgery, University of Melbourne and Royal Melbourne Hospital, Parkville, Victoria, Australia. [email protected].

PMID: 25225066
DOI: 10.1158/1078-0432.CCR-14-1536

No abstract available

Publication types

Letter
Comment

MeSH terms

Androgens / metabolism*
Androstenedione / metabolism*
Drug Resistance, Neoplasm / physiology*
Humans
Male
Prostatic Neoplasms / metabolism*

Substances

Androgens
Androstenedione